ROYAL BANK OF CANADA - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAA4. A total of 10 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$4,0000.0%4,0000.0%0.00%
Q3 2018$4,0000.0%4,0000.0%0.00%
Q2 2018$4,0000.0%4,0000.0%0.00%
Q1 2018$4,0000.0%4,0000.0%0.00%
Q4 2017$4,0000.0%4,0000.0%0.00%
Q3 2017$4,0000.0%4,0000.0%0.00%
Q2 2017$4,0004,0000.00%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
STEELHEAD PARTNERS LLC 42,500,000$43,297,0003.73%
Mohican Financial Management, LLC 6,000,000$6,056,0002.34%
GRACE BROTHERS MANAGEMENT LLC 1,750,000$1,781,0001.66%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 34,520,000$34,986,0001.43%
SILVERBACK ASSET MANAGEMENT LLC 12,250,000$12,472,0000.88%
Man Investments (CH) AG 1,800,000$1,845,0000.74%
SCHRODER INVESTMENT MANAGEMENT GROUP 5,000,000$510,380,000,0000.58%
WOLVERINE ASSET MANAGEMENT LLC 21,109,000$21,536,0000.46%
Wellesley Asset Management 6,611$6,707,0000.43%
DINSMORE CAPITAL MANAGEMENT CO/NJ 1,000,000$1,013,0000.40%
View complete list of AMAG PHARMACEUTICALS INC shareholders